Concepedia
Statistics
Publications
17
Citations
612
H-Index
13
Active since
1995
Affiliations
Universidad de Buenos Aires(Current)
Pfizer (United States)
UCSF Benioff Children's Hospital
University of California Davis Medical Center
Sangamo BioSciences (United States)
Pablo Rendo is an author at Universidad de Buenos Aires specializing in medicine, hematology, and chronic kidney disease.
Top concepts
MedicineHematologyPathologyNephrologyHemodialysisChronic Kidney DiseaseAgingAnemiaHealthDialysis
Publications per year
1995–2024
Effect of Early Versus Late Administration of Human Recombinant Erythropoietin on Transfusion Requirements in Premature Infants: Results of a Randomized, Placebo-Controlled, Multicenter Trial
Hugo Donato, Néstor Vain, Pablo Rendo et al. · PEDIATRICS · 2000 · 103 citations
Multicentre, randomized, open‐label study of on‐demand treatment with two prophylaxis regimens of recombinant coagulation factor IX in haemophilia B subjects
Leonard A. Valentino, L. Rusen, Ivo Elezović et al. · Haemophilia · 2014 · 88 citations
A double‐blind controlled trial of recombinant interferon‐α2b in haemodialysis patients with chronic hepatitis C virus infection and abnormal aminotransferase levels
José Luis Fernández, Pablo Rendo, Noemí del Pino · Journal of Viral Hepatitis · 1997 · 62 citations
Phase II trial of recombinant interferon-alpha2b in patients with advanced intractable multidrug-resistant pulmonary tuberculosis: long-term follow-up.
Domingo Palmero, Kumiko Eiguchi, Pablo Rendo et al. · PubMed · 1999 · 55 citations
Once‐weekly prophylactic treatment vs. on‐demand treatment with nonacog alfa in patients with moderately severe to severe haemophilia B
Lynne M. Smith, Kazimierz Kuliczkowski, Joan Korth‐Bradley et al. · Haemophilia · 2016 · 52 citations · Full text
1–5 of 17